INDEPENDENT INTELLIGENCE
LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Parabilis Medicines, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERPBLS
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / PBLS COVERAGE

What’s moving Parabilis Medicines, Inc. now

Current reporting with the operating signal separated from the noise.

01
Parabilis Medicines, Inc. (PBLS) Receives a Buy from LifeSci Capital

Parabilis Medicines, Inc. (PBLS) Receives a Buy from LifeSci Capital

The story matters when it changes Parabilis Medicines, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest PBLS filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

8-KMaterial company eventFiled 2026-06-11 · Period 2026-06-09SEC ↗4Official SEC filingFiled 2026-07-22 · Period 2026-07-20SEC ↗4Official SEC filingFiled 2026-06-29 · Period 2026-06-11SEC ↗3Official SEC filingFiled 2026-06-29 · Period 2026-06-09SEC ↗SCHEDULE 13DOfficial SEC filingFiled 2026-06-18SEC ↗4Official SEC filingFiled 2026-06-16 · Period 2026-06-12SEC ↗4Official SEC filingFiled 2026-06-15 · Period 2026-06-11SEC ↗4Official SEC filingFiled 2026-06-15 · Period 2026-06-09SEC ↗
EARNINGS / QUARTERLY TRACKER

Parabilis Medicines, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.